Literature DB >> 24651918

Anti-CCP antibodies in Brazilian children and adults with juvenile idiopathic arthritis.

S Bacos1, S G Bortolozzi, T S Skare, P F Spelling, S R R Utiyama, R Nisihara.   

Abstract

Patients with juvenile idiopathic arthritis (JIA) may need further care in the adult clinic as this disease frequently has continuous inflammatory activity during adult life. To identify which pediatric JIA patients will need continuing care into adulthood. We compared the clinical, serological, and demographic data of 45 JIA patients followed up by the pediatric clinic to those of 49 JIA patients in the adult rheumatology clinic. Patients in the adult clinic have older age at disease onset (p < 0.0001) and higher prevalence of positive anti-cyclic citrullinated peptide (CCP) (p = 0.05). No differences were observed in JIA form, presence of rheumatoid factor (RF), uveitis, and gender. Anti-CCP and older age at disease onset may identify pediatric JIA patients that will need further care in the adult clinic.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24651918     DOI: 10.1007/s10067-014-2578-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  17 in total

1.  International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001.

Authors:  Ross E Petty; Taunton R Southwood; Prudence Manners; John Baum; David N Glass; Jose Goldenberg; Xiaohu He; Jose Maldonado-Cocco; Javier Orozco-Alcala; Anne-Marie Prieur; Maria E Suarez-Almazor; Patricia Woo
Journal:  J Rheumatol       Date:  2004-02       Impact factor: 4.666

Review 2.  Juvenile idiopathic arthritis.

Authors:  Angelo Ravelli; Alberto Martini
Journal:  Lancet       Date:  2007-03-03       Impact factor: 79.321

3.  Anti-cyclic citrullinated peptide (anti-CCP) antibodies in children with juvenile idiopathic arthritis.

Authors:  Marion van Rossum; Renée van Soesbergen; Sandra de Kort; Rebecca ten Cate; Aeilko H Zwinderman; Ben de Jong; Ben Dijkmans; Walther J van Venrooij
Journal:  J Rheumatol       Date:  2003-04       Impact factor: 4.666

Review 4.  Long-term outcomes and predictors of outcomes for patients with juvenile idiopathic arthritis.

Authors:  Kiem Oen
Journal:  Best Pract Res Clin Rheumatol       Date:  2002-07       Impact factor: 4.098

5.  Increased mortality in adults with a history of juvenile rheumatoid arthritis: a population-based study.

Authors:  A R French; T Mason; A M Nelson; W M O'Fallon; S E Gabriel
Journal:  Arthritis Rheum       Date:  2001-03

Review 6.  Juvenile idiopathic arthritis.

Authors:  Andrea T Borchers; Carlo Selmi; Gurtej Cheema; Carl L Keen; Yehuda Shoenfeld; M Eric Gershwin
Journal:  Autoimmun Rev       Date:  2005-10-27       Impact factor: 9.754

7.  How do we organize smooth, effective transfer from paediatric to adult diabetes care?

Authors:  Marg McGill
Journal:  Horm Res       Date:  2002

8.  Anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis.

Authors:  R Gupta; M M Thabah; B Vaidya; S Gupta; R Lodha; S K Kabra
Journal:  Indian J Pediatr       Date:  2010-02-05       Impact factor: 1.967

9.  Antibodies against cyclic citrullinated peptide are associated with HLA-DR4 in simplex and multiplex polyarticular-onset juvenile rheumatoid arthritis.

Authors:  Elizabeth D Ferucci; Darcy S Majka; Lezlie A Parrish; Marta B Moroldo; Mary Ryan; Murray Passo; Susan D Thompson; Kevin D Deane; Marian Rewers; William P Arend; David N Glass; Jill M Norris; V Michael Holers
Journal:  Arthritis Rheum       Date:  2005-01

10.  Burden of childhood-onset arthritis.

Authors:  Lakshmi N Moorthy; Margaret Ge Peterson; Afton L Hassett; Thomas Ja Lehman
Journal:  Pediatr Rheumatol Online J       Date:  2010-07-08       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.